Bimzelx on Blue MedicareRx Premier (S2893-003)
bimekizumab
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 2 per 28 days.
$5,264.57
Patient pays / month
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
BIMZELX 160 mg/mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $15,953.24 for a month. Other covered strengths are listed below.
Prior authRequired on all 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| BIMZELX 160 mg/mL Injection, Solution | 5 | $5,264.57 | PA · 2 per 28 days |
| BIMZELX 160 mg/mL Injection, Solution | 5 | $5,295.38 | PA · 2 per 28 days |
| BIMZELX 320 mg/2mL Injection, Solution | 5 | $11,282.23 | PA · 4 per 28 days |
| BIMZELX 320 mg/2mL Injection, Solution | 5 | $11,282.23 | PA · 4 per 28 days |
Other IL-17 and IL-23 biologics on this plan
Verify with the plan before prescribing or filling. Member services: (888)543-4917. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s2893-003